BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9683147)

  • 1. Anterior uveitis associated with latanoprost.
    Fechtner RD; Khouri AS; Zimmerman TJ; Bullock J; Feldman R; Kulkarni P; Michael AJ; Realini T; Warwar R
    Am J Ophthalmol; 1998 Jul; 126(1):37-41. PubMed ID: 9683147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latanoprost 0.005% and anterior segment uveitis.
    Smith SL; Pruitt CA; Sine CS; Hudgins AC; Stewart WC
    Acta Ophthalmol Scand; 1999 Dec; 77(6):668-72. PubMed ID: 10634560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular complications of latanoprost in uveitic glaucoma: three case reports.
    SaccĂ  S; Pascotto A; Siniscalchi C; Rolando M
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):107-13. PubMed ID: 11324978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
    Ramasamy B; Quah S; Sahni JN; Palimar P
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):513-5. PubMed ID: 17900233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CME and anterior uveitis with latanoprost use.
    Thorne JE; Maguire AM; Lanciano R
    Ophthalmology; 1998 Nov; 105(11):1981-3. PubMed ID: 9818590
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension.
    Moroi SE; Gottfredsdottir MS; Schteingart MT; Elner SG; Lee CM; Schertzer RM; Abrams GW; Johnson MW
    Ophthalmology; 1999 May; 106(5):1024-9. PubMed ID: 10328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients.
    Warwar RE; Bullock JD; Ballal D
    Ophthalmology; 1998 Feb; 105(2):263-8. PubMed ID: 9479285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystoid macular edema associated with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier.
    Furuichi M; Chiba T; Abe K; Kogure S; Iijima H; Tsukahara S; Kashiwagi K
    J Glaucoma; 2001 Jun; 10(3):233-6. PubMed ID: 11442189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latanoprost-associated cystoid macular edema.
    Callanan D; Fellman RL; Savage JA
    Am J Ophthalmol; 1998 Jul; 126(1):134-5. PubMed ID: 9683162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior uveitis associated with fixed-combination latanoprost and timolol.
    Ornek K; Onaran Z; Turgut Y
    Can J Ophthalmol; 2008 Dec; 43(6):727-8. PubMed ID: 19020649
    [No Abstract]   [Full Text] [Related]  

  • 11. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
    Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
    Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost.
    Krishnamurthy R; Senthil S; Garudadri CS
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26174734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iris cyst associated with topical administration of latanoprost.
    Krohn J; Hove VK
    Am J Ophthalmol; 1999 Jan; 127(1):91-3. PubMed ID: 9933009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
    Becker HI; Walton RC; Diamant JI; Zegans ME
    Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
    [No Abstract]   [Full Text] [Related]  

  • 18. Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma.
    Hu J; Vu JT; Hong B; Gottlieb C
    Br J Ophthalmol; 2020 Aug; 104(8):1040-1044. PubMed ID: 32532763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal.
    Waheed K; Laganowski H
    Eye (Lond); 2001 Jun; 15(Pt 3):347-9. PubMed ID: 11450742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.